The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zogenix, Inc(NASDAQ:ZGNX) 
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials...
Website: http://www.zogenix.com
Full Time Employees: 218 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Zogenix Days Payable Outstanding ttm (DPO)
Zogenix Days Receivable Outstanding ttm (DSO)
Zogenix Days Inventory Outstanding ttm (DIO)
Zogenix Op Cashflow Per Share ttm
Zogenix Free Cashflow Per Share ttm
Zogenix Cash Per Share ttm
Zogenix P/S ratio ttm
Zogenix (GAAP) P/E ratio ttm
Zogenix P/B ratio ttm
No extra charts and metrics for this ticker.